PRACTITIONER’S CORNER - rihuc.huc.min-saude.pt.pdfVIP

PRACTITIONER’S CORNER Diego, California, USA) and FoxP3 (eBioscience, San Diego, Peripheral Dendritic Cells in Asthma California, USA) [5]. Fifty-four healthy controls were also enrolled. The Mann-Whitney test, Spearman test, and multiple 1 2 1 2 3 Á Cseh, A Bohács, B Szalay, G Losonczy, T Tulassay, regressions were applied using Statistica 8 (Statsoft, Tulsa, B Vásárhelyi,1,4 L Tamási2 Oklahoma, USA). 1Research Group for Pediatrics and Nephrology, Semmelweis Total DC prevalence (Lin1–HLA-DR+/PBMCs) was University and Hungarian Academy of Sciences, Budapest, comparable in both asthma patients and controls (1.19 [0.77- Hungary 1.54] vs 1.16 [0.60-2.60]). The prevalence values for mDC 2Department of Pulmonology, Semmelweis University, + – + – (CD11c CD123 /DCs) and pDC (CD123 CD11c /DCs) were Budapest, Hungary also comparable (59.64 [52.07-65.19] vs 63.65 [56.02-72.31] 3First Department of Pediatrics, Semmelweis University, and 31.36 [18.26-36.22] vs 25.57 [22.25-32.34], respectively). Budapest, Hungary The mDC/pDC ratio was lower in asthma patients than in 4Department of Laboratory Medicine, Semmelweis University,